TreeFrog Therapeutics
Created in 2018
- BETA
Trend leader (A+)
Existing signals make this entity one of the most dynamic startups Social networks
913 18,448Global tags
Activities
Technologies
Entity types
Location
30 Av. Gustave Eiffel Bat A, 33600 Pessac, France
Pessac
France
Employees
Scale: 51-200
Estimated: 151
SIREN
343619102Engaged corporates
38
15 26Added in Motherbase
4 years, 11 months ago
deeptech Value proposition
Cell Therapy for All
TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients.
TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality.
Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a technological hub in Boston, USA to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.
Cell Therapy, Stem Cell, Stem cell mass-production, Cell therapy cGMP manufacturing, biomimetic 3D cell culture, and bioreactor stem cell cultivationOriginal language
Cell Therapy for All
TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients.
TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality.
Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a technological hub in Boston, USA to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.
TreeFrog Therapeutics I iPS-derived Cell Therapies I Cell Therapy for All
TreeFrog Therapeutics aims at making iPS-derived cell therapies safer, more efficient and more affordable to cure millions of patients.
https://treefrog.fr/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Moderna Pharmaceutical, Biotechnology, Biotechnology Research | Moderna Pharmaceutical, Biotechnology, Biotechnology Research | Not capitalistic Partnership Event 15 Nov 2021 | | |
 BFM Business Media, Broadcast Media Production and Distribution | BFM Business Media, Broadcast Media Production and Distribution | Not capitalistic Not partnership Event 26 Apr 2024 | | |
 AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 18 Jan 2022 | | |
 Région Nouvelle-Aquitaine National and local authorities, Government Administration | Région Nouvelle-Aquitaine National and local authorities, Government Administration | Other 13 Dec 2018 22 May 2024 | | |
 Le Journal des Entreprises Media, Newspaper Publishing | Le Journal des Entreprises Media, Newspaper Publishing | Other 24 Apr 2024 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Not capitalistic Not partnership Event 6 Dec 2021 22 May 2024 | | |
 La French Tech Media, Government Administration | La French Tech Media, Government Administration | Not capitalistic Partnership Event 30 May 2024 | | |
 SATT CONECTUS Research, Research Services | SATT CONECTUS Research, Research Services | Other 11 May 2024 | | |
 CNRS Research, Research Services | CNRS Research, Research Services | Other 22 May 2024 | | |
 Kurma Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Kurma Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 13 Oct 2022 | | |